These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 6092407

  • 1. Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion.
    Schürmeyer TH, Avgerinos PC, Gold PW, Gallucci WT, Tomai TP, Cutler GB, Loriaux DL, Chrousos GP.
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1103-8. PubMed ID: 6092407
    [Abstract] [Full Text] [Related]

  • 2. Effects and pharmacokinetic properties of the rat/human corticotropin-releasing factor in rhesus monkeys.
    Schürmeyer TH, Gold PW, Gallucci WT, Tomai TP, Cutler GB, Loriaux DL, Chrousos GP.
    Endocrinology; 1985 Jul; 117(1):300-6. PubMed ID: 2988919
    [Abstract] [Full Text] [Related]

  • 3. Intravenous application of ovine and human corticotropin releasing factor (CRF): ACTH, cortisol and CRF levels.
    Stalla GK, Hartwimmer J, Schopohl J, von Werder K, Müller OA.
    Neuroendocrinology; 1986 Jul; 42(1):1-5. PubMed ID: 3001563
    [Abstract] [Full Text] [Related]

  • 4. Effect of subcutaneous and intranasal administration of ovine corticotropin-releasing hormone in man: comparison with intravenous administration.
    DeBold CR, Sheldon WR, DeCherney GS, Jackson RV, Nicholson WE, Island DP, Orth DN.
    J Clin Endocrinol Metab; 1985 May; 60(5):836-40. PubMed ID: 2984233
    [Abstract] [Full Text] [Related]

  • 5. Effect of synthetic ovine corticotropin-releasing factor: prolonged duration of action and biphasic response of plasma adrenocorticotropin and cortisol.
    DeBold CR, DeCherney GS, Jackson RV, Sheldon WR, Alexander AN, Island DP, Rivier J, Vale W, Orth DN.
    J Clin Endocrinol Metab; 1983 Aug; 57(2):294-8. PubMed ID: 6306038
    [Abstract] [Full Text] [Related]

  • 6. Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor.
    DeBold CR, Sheldon WR, DeCherney GS, Jackson RV, Alexander AN, Vale W, Rivier J, Orth DN.
    J Clin Invest; 1984 Feb; 73(2):533-8. PubMed ID: 6321557
    [Abstract] [Full Text] [Related]

  • 7. Clinical studies with synthetic ovine corticotropin-releasing factor.
    Orth DN, DeBold CR, DeCherney GS, Jackson RV, Sheldon WR, Nicholson WE, Uderman H, Alexander AN, Island DP, Rivier J.
    Fed Proc; 1985 Jan; 44(1 Pt 2):197-202. PubMed ID: 2981741
    [Abstract] [Full Text] [Related]

  • 8. Responses of plasma adrenocorticotropin and cortisol to intravenous injection of synthetic ovine corticotropin releasing factor in the morning and early evening in normal human subjects.
    Watabe T, Tanaka K, Hasegawa M, Miyabe S, Shimizu N.
    Endocrinol Jpn; 1985 Oct; 32(5):771-9. PubMed ID: 3004929
    [Abstract] [Full Text] [Related]

  • 9. Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol.
    Orth DN, Jackson RV, DeCherney GS, DeBold CR, Alexander AN, Island DP, Rivier J, Rivier C, Spiess J, Vale W.
    J Clin Invest; 1983 Mar; 71(3):587-95. PubMed ID: 6298280
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of ovine and human corticotrophin-releasing factor in human subjects.
    Hermus AR, Pieters GF, Pesman GJ, Buys WC, Smals AG, Benraad TJ, Kloppenborg PW.
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):589-95. PubMed ID: 6094049
    [Abstract] [Full Text] [Related]

  • 11. Corticotropin releasing factor (CRF): diagnostic implications.
    Müller OA, Stalla GK, Hartwimmer J, Schopohl J, von Werder K.
    Acta Neurochir (Wien); 1985 Nov; 75(1-4):49-59. PubMed ID: 2986422
    [Abstract] [Full Text] [Related]

  • 12. Ovine (o) and human (h) corticotrophin releasing factor (CRF) in man: CRF-stimulation and CRF-immunoreactivity.
    Stalla GK, Hartwimmer J, von Werder K, Müller OA.
    Acta Endocrinol (Copenh); 1984 Jul; 106(3):289-97. PubMed ID: 6331035
    [Abstract] [Full Text] [Related]

  • 13. Dose-response effects of exogenous pulsatile human corticotropin-releasing hormone on adrenocorticotropin, cortisol, and gonadotropin concentrations in agonadal women.
    Thomas MA, Rebar RW, LaBarbera AR, Pennington EJ, Liu JH.
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1249-54. PubMed ID: 1851183
    [Abstract] [Full Text] [Related]

  • 14. Effect of adrenalectomy or long term cortisol or adrenocorticotropin (ACTH)-releasing factor infusion on the concentration and molecular weight distribution of ACTH in fetal sheep plasma.
    Ozolins IZ, Antolovich GC, Browne CA, Perry RA, Robinson PM, Silver M, McMillen IC.
    Endocrinology; 1991 Oct; 129(4):1942-50. PubMed ID: 1655390
    [Abstract] [Full Text] [Related]

  • 15. Assessment of pituitary function after transsphenoidal hypophysectomy in beagle dogs.
    Meij BP, Mol JA, van den Ingh TS, Bevers MM, Hazewinkel HA, Rijnberk A.
    Domest Anim Endocrinol; 1997 Mar; 14(2):81-97. PubMed ID: 9063651
    [Abstract] [Full Text] [Related]

  • 16. Plasma distribution, disappearance half-time, metabolic clearance rate, and degradation of synthetic ovine corticotropin-releasing factor in man.
    Nicholson WE, DeCherney GS, Jackson RV, DeBold CR, Uderman H, Alexander AN, Rivier J, Vale W, Orth DN.
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1263-9. PubMed ID: 6313734
    [Abstract] [Full Text] [Related]

  • 17. Corticotropin-releasing factor (CRF): stimulation in normal controls and in patients with Cushing's syndrome.
    Müller OA, Hartwimmer J, Hauer A, Kaliebe T, Schopohl J, Stalla GK, von Werder K.
    Psychoneuroendocrinology; 1986 Dec; 11(1):49-60. PubMed ID: 3010360
    [Abstract] [Full Text] [Related]

  • 18. Pituitary and adrenal responses to pulsatile ovine corticotropin-releasing factor administered to fetal sheep.
    Brooks AN, Challis JR, Norman LJ.
    Endocrinology; 1987 Jun; 120(6):2383-8. PubMed ID: 3032589
    [Abstract] [Full Text] [Related]

  • 19. Diurnal variation in the response of plasma adrenocorticotropin and cortisol to intravenous ovine corticotropin-releasing hormone.
    DeCherney GS, DeBold CR, Jackson RV, Sheldon WR, Island DP, Orth DN.
    J Clin Endocrinol Metab; 1985 Aug; 61(2):273-9. PubMed ID: 2989316
    [Abstract] [Full Text] [Related]

  • 20. Intrahypothalamic action of corticotrophin-releasing factor (CRF) to inhibit growth hormone and LH release in the rat.
    Ono N, Lumpkin MD, Samson WK, McDonald JK, McCann SM.
    Life Sci; 1984 Sep 03; 35(10):1117-23. PubMed ID: 6090831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.